FDA Adverse Event Injury Summary report: N

REVERSE SHOULDER SYSTEM 04.01.0155 GLENOID BASEPLATE Ø27X25

MDR report key: 16680117 · Received April 5, 2023

Report

Report Number
3005180920-2023-00210
Event Type
Injury
Date Received
April 5, 2023
Date of Event
March 6, 2023
Report Date
April 5, 2023
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
PHX
UDI-DI
07630040706421
PMA / PMN Number
K170452
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON (B)(6) 2023: LOT 2006582: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 11-NOV-2020. EXPIRATION DATE: 2025-11-02. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. OTHER DEVICES INVOLVED: REVERSE SHOULDER SYSTEM 04.01.0163 GLENOID POLYAXIAL LOCKING SCREW - L38 LOT. 2005661 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 26-AUG-2020. EXPIRATION DATE: 2025-08-17. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. REVERSE SHOULDER SYSTEM 04.01.0161 GLENOID POLYAXIAL LOCKING SCREW - L30 LOT. 2002443 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 01-JULY-2020. EXPIRATION DATE: 2025-05-17. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. REVERSE SHOULDER SYSTEM 04.01.0211 LAT. GLENOSPHERE 39XØ27 LOT. 189945 (K193175): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 14-MAY-2019. EXPIRATION DATE: 2024-05-01. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. RESTERILIZED DEVICES OF THIS LOT CONSIDERED IN THIS BATCH. REVERSE SHOULDER SYSTEM 04.01.0158 GLENOID POLYAXIAL LOCKING SCREW - L18 LOT. 2002440 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 26-AUG-2020. EXPIRATION DATE: 2025-08-18. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH ANOTHER SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. 2 DEVICES OF THIS LOT INVOLVED IN THIS COMPLAINT. REVERSE SHOULDER SYSTEM 04.01.0110 HUMERAL REVERSE METAPHYSIS +0MM/0° LOT. 2001815 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 16-OCT-2020. EXPIRATION DATE: 2025-10-07. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. REVERSE SHOULDER SYSTEM 04.01.0158 GLENOID POLYAXIAL LOCKING SCREW - L18 LOT. 2002440 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 26-AUG-2020. EXPIRATION DATE: 2025-08-18. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH ANOTHER SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. 2 DEVICES OF THIS LOT INVOLVED IN THIS COMPLAINT. REVERSE SHOULDER SYSTEM 04.01.0007 STD HUMERAL DIAPHYSIS - CEMENTLESS - 12 LOT. 1910843 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 16-MAR-2020. EXPIRATION DATE: 2025-03-04. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW. REVERSE SHOULDER SYSTEM 04.01.0122 HUMERAL REVERSE HC LINER Ø39/+0MM LOT. 2006593 (K170452): (B)(4) ITEMS MANUFACTURED AND RELEASED ON 12-NOV-2020. EXPIRATION DATE: 2025-10-29. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL THE ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT IN THE PERIOD OF REVIEW.

Description of Event or Problem · 0

REVISION SURGERY FOR INFECTION AT ABOUT 2 YEARS AND 1 MONTH AFTER PRIMARY. THE SURGEON REVISED SUCCESSFULLY ALL THE DEVICES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2242210 REVERSE SHOULDER SYSTEM 04.01.0155 GLENOID BASEPLATE Ø27X25 SHOULDER GLENOID BASEPLATE PHX MEDACTA INTERNATIONAL SA 04.01.0155 2006582 07630040706421

Patients

Seq Age Sex Outcome Treatment
1 65 YR Male Required Intervention